Abonner Johnson & Johnson and Janssen

Johnson & Johnson and Janssen

  • 13.12.2012 – 11:23

    CellSearch® 'Liquid Biopsy' Approved for Breast Cancer Patients in China

    Raritan, New Jersey (ots/PRNewswire) - Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch(R) circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer. This makes CellSearch(R) the first and only approved CTC test for cancer patients in China, which is the seventh ...